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Abstract
In sugar cataract formation in rats, aldose reductase (AR) actitvity is not only linked to lenticular
sorbitol (diabetic) or galactitol (galactosemic) formation but also to signal transduction changes,
cytotoxic signals and activation of apoptosis. Using both in vitro and in vivo techniques, the
interrelationship between AR activity, polyol (sorbitol and galactitol) formation, osmotic stress,
growth factor induction, and cell signaling changes have been investigated. For in vitro studies,
lenses from Sprague Dawley rats were cultured for up to 48 hrs in TC-199-bicarbonate media
containing either 30 mM fructose (control), or 30 mM glucose or galctose with/without the aldose
reductase inhibitors AL1576 or tolrestat, the sorbitol dehydrogenase inhibitor (SDI) CP-470,711,
or 15 mM mannitol (osmotic-compensated media). For in vivo studies, lenses were obtained from
streptozotocin-induced diabetic Sprague Dawley rats fed diet with/without the ARIs AL1576 or
tolrestat for 10 weeks. As expected, lenses cultured in high glucose / galactose media or from
untreated diabetic rats all showed a decrease in the GSH pool that was lessened by ARI treatment.
Lenses either from diabetic rats or from glucose/galactose culture conditions showed increased
expression of basic-FGF, TGF-β, and increased signaling through P-Akt, P-ERK1/2 and P-SAPK/
JNK which were also normalized by ARIs to the expression levels observed in non-diabetic
controls. Culturing rat lenses in osomotically compensated media containing 30 mM glucose or
galactose did not lead to increased growth factor expression or altered signaling. These studies
indicate that it is the biophysical response of the lens to osmotic stress that results in an increased
intralenticular production of basic-FGF and TGF-β and the altered cytotoxic signaling that is
observed during sugar cataract formation.
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Introduction
Cataracts in diabetic or galactosemic animals are directly linked to the aldose reductase
(AR) catalyzed accumulation of sorbitol from glucose or galactitol from galactose. Excess
accumulation of these polyols (sorbitol or galactitol) initiates osmotic stress that alters lens
cell permeability, decreases ATPase activity, decreases crystallin synthesis, reduces amino
acid uptake and alters redox homeostasis (Cheng and Gonzalez, 1986; Kador, 1994;
Kinoshita, 1974; Lee and Chung, 1999). Osmotic stress can also initiate endoplasmic
reticulum (ER) stress that induces an unfolded protein response (UPR) which results in
oxidative stress through the formation of reactive oxygen species (ROS) and apoptosis
(Mulhern et al., 2006; Zhang et al., 2009) . AR activity is primarily located in the
metabolically active epithelial cell layer and the differentiating epithelial cells at the
equatorial region (Akagi et al., 1987; Akagi et al., 1988; Akagi et al., 1986; Akagi et al.,
1984). These cells contain mitochondria that can participate in the UPR. Lens epithelial cells
also possess receptors to basic fibroblast growth factor (bFGF) and transforming growth
factor-β (TGF-β). All of these growth factors can alter lens physiology (He et al., 2007;
Ibaraki et al., 1995, 1996; Kampmeier et al., 2006; Schneider et al., 2010).
Binding of bFGF or TGF-β to lens cell surface receptors initiates cell signaling pathways
that include the MAPK/ERK signal transduction pathway. MAPKs comprise a family of
ubiquitous proline-directed, protein-serine/threonine kinases, including c-Jun N-terminal
kinases/stress-activated protein kinases (JNK/SAPKs), extracellular signal-regulated kinases
1 and 2 (ERK1 and ERK2), c-Raf, and p38 Pathways, which are activated by
phosphorylation cascades and respond to extracellular stimuli (mitogens) and regulate
various cellular activities, such as gene expression, mitosis, differentiation, proliferation, and
cell survival/apoptosis (Pearson et al., 2001). All MAPK pathways operate through
sequential phosphorylation events to activate transcription factors and regulate gene
expression.
Another important groups of molecules in cellular signaling is the Akt protein family which
are located downstream of the phosphatidylinositol 3-kinases (PI3Ks) family of enzymes.
The PI3K-Akt signaling pathway has been implicated in glucose metabolism, protein
synthesis, receptor insertion, cytoskeletal reorganization and cell proliferation. However,
Akts are most commonly associated with cell survival because they inhibit the activation of
proapoptotic proteins and transcription factors (Aberg et al., 2003; Brazil et al., 2004).
Lens cells respond to outside stimuli through signal transduction which involves ordered
sequences of biochemical reactions inside the cell in response to ligand binding or G-protein
coupled receptors. Signaling changes in lens cells have been linked to the glucose-derived
imbalance of metabolic homeostasis that occurs during diabetic cataract formation
(Zatechka et al., 2003). AR activity has also been linked to signal transduction changes,
cytotoxic signaling and activation of apoptosis. Exposure of cultured human epithelial cells
to chronic hyperglycemia or the growth factor TNF-α causes cell death that is attenuated by
inhibition of AR (Ramana et al., 2003). Inhibition of AR inhibition also prevents the
activation of ERK1/2, JNK, and NF-κB in pig lens epithelial cells exposed to bFGF (Yadav
et al., 2009). In diabetic rat lenses, ARIs also normalized the suppression of PI-3K and P-
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Raf-1 and increase of P-MEK, P-ERK, PPAK2, P-p38, and P-JNK (Zatechka et al., 2003).
Pig lenses cultured in vitro in 30 mM galactose also demonstrate activation of both the Raf-
MEK-ERK and PI-3K-Akt pathways, and this activation is reduced by inhibition of AR
(Zatechka and Lou, 2002). The observed signaling changes under both hyperglycemic and
galactosemic conditions and their normalization by the presence of ARIs strongly suggest
that these signaling changes are linked to AR activity. In this study, we have demonstrated
that high glucose or galactose-induces bFGF and TGFβ expression in the lens and that the
associated cell signaling responses can be controlled by ARI via the drug’s ability to prevent
osmotic stress.
Material and Methods
All procedures involving live animals were performed in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory Animals and the Association
for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic
and Vision Research under protocol 05-102-01 approved by the University of Nebraska
Medical Center Institutional Animal Care and Use Committee (IACUC).
Three-week-old (100 g) male Sprague-Dawley rats were purchased from the Sasco Division
of Charles River Laboratories (Wilmington, MA). Spiro-(2,7-difluoro-7H-fluorene-9,4′-
imidazolidine)-2′-5′-dione (AL1576) was obtained from Alcon Laboratories (Fort Worth,
TX) and tolrestat (N -[(5-trifluoromethyl-6-methoxy-1-naphthalenyl)thioxomethyl]-N-
methyl-glycine) was obtained from Wyeth-Ayerst Laboratories (Princeton, NJ). The SDI
CP-166,572 (4-[4-(N,N-dimethylsulfamoyl)-piperazino]-2-hydroxymethylpyrimidine) was
obtained from Pfizer Inc (Groton, CT). TC-199 medium (without phenol red indicator and
glutamine) was supplied by the NIH media unit. All bFGF rabbit monoclonal antibody,
TGF-β rabbit monoclonal antibody and the phospho-Akt (Ser473) rabbit monoclonal
antibody, phospho-ERK1/2 (phospho-44/42 MAPK) (Thr202/Tyr204) rabbit monoclonal
antibody, phospho-SAPK/JNK monoclonal antibody and GAPDH rabbit monoclonal
antibody were obtained from Cell Signaling Technologies (Beverly, MA). The enhanced
chemiluminescence system components, including horseradish peroxidase (HRP)
conjugated anti-rabbit antibody and chemiluminescent reagent were obtained from Cell
Signaling Technologies (Beverly, MA). Electrophoretic materials all were obtained from
Bio-Rad Laboratories (Hercules, CA). All other chemicals were of analytical grade.
In vivo Diabetic Studies
Diabetes was induced in young (100 g) Sprague Dawley rats by tail vein injection of 75 mg/
kg of streptozotocin (Kador et al., 2010a). All rats with blood glucose levels > 300 mg/dl
were then equally divided into 3 groups of 8 each. The first diabetic group of 8 rats received
standard rat diet (Bioserve, Frenchtown, NJ); the second diabetic group of 8 rats received
similar rat diet containing 0.015% of tolrestat, the third diabetic group of 8 rats received
similar diet containing 0.0125% AL1576. Experimental diets were initiated 10 days
following initial streptozotocin injections and continued for 10 weeks until the studies were
terminated. Age-matched nondiabetic rats were used as controls. Blood glucose levels at the
inset of the study were evaluated using a commercial glucometer (Freestyle by TheraSense,
Alameda, CA) and HbA1C levels at the end of the study were measured using measured
using a test kit (Bayer Metrika A1cNOW Plus System, San Diego, CA). Rats were killed by
CO2 asphyxiation, their eyes were enucleated, and the lenses were surgically removed by
posterior approach from the enucleated eyes. A minimum of 4 rats per group were used for
Western Blot analysis.
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Lenses Culture Studies
Young (100 g) Sprague Dawley rats were asphyxiated with carbon dioxide. After death, the
eyes were enucleated and the lens from each eye was removed by careful dissection from a
posterior approach and incubated in sterile TC-199 - bicarbonate media containing 20 U mL/
L of penicillin-streptomycin in a humidified incubator under an atmosphere of 95% air and
5% CO2 at 37° (Shiono et al., 1985). After 4 hr each lens was examined under a dissecting
microscope and each optically clear, intact (no capsular tear) lens was placed in 24-well
culture plates containing 2 ml of sterile TC-199 - bicarbonate media containing 20 U mL/L
of penicillin-streptomycin per well as follows: culture medium containing 30 mmol fructose
(control), culture medium containing 30 mmol/l glucose or galactose, culture medium
containing 30 mmol/l glucose or galactose with 10 µM AL1576, culture medium containing
30 mmol glucose or galactose with 10 µM tolrestat, culture medium containing 30 mmol
glucose or galactose with 10 µM of the SDI CP-470,711, culture medium containing 30
mmol/l glucose or galactose with 15 mM mannitol. They were then cultured for up to 48 hr.
At the end of the study each lens was examined for morphological changes and then
removed from the culture dish, carefully blotted on wet filter paper, weighted, and then
immediately frozen for subsequent analysis.
Lens Polyol Levels
Each lens was homogenized in a ground glass homogenizer and an aliquot of the
homogenate was removed for colorimetric protein quantification using the DC Protein
Assay (Bio-Rad Laboratories, Hercules, CA) and bovine serum albumin (BSA) protein
standards. Three micromoles of xylitiol were added to each remaining homogenate as an
internal standard and the homogenates were deproteinized by overnight centrifugation at 8°
C in Microcon YM-10 Centrifugal Filters. Each filtrate was dried in a Speedvac, and the
residues were dissolved in 900 µL of pyridine and derivatized with 900 µL of phenyl
isocyanate at 55° C for 60 min. After cooling in an ice bath, cold methanol was added to
each mixture followed by additional heating for 5 min. The derivatized samples were
analyzed by HPLC on an automated Hewlet Packard 1100 Chemstation equipped with a
diode array detector. Samples (5 µL) were injected onto a 150×4.6 mm Tosoh TSK-GEL
ODS-80Tm column containing a 3.2×15 mm guard column at 35° C. Samples were
isocratically eluted with 20 mmol/l potassium phosphate/acetonitrile (35:65 v%) buffer, pH
7.0, at a flow rate of 1.0 ml/min and detected at 235 nm. Samples were quantified against
standard curve of sorbitol (0.008-6.0 µmoL).
GSH Levels
Each lens was homogenized in a ground glass homogenizer and the insoluble proteins were
removed by centrifugation at 4°C. Protein levels in an aliquot from each supernatant were
measured according to Bradford Assay (Bradford, 1976). The remaining cell supernatants
were then deproteinized with equal volumes of 20% TCA and GSH levels in the
deproteinized supernatant were measured at 412 nm according to the DTNB method (Lou
and Dickerson, 1992).
PAGE and Western Immunoblot Analyses
Each lens was homogenized in a ground glass homogenizer with ice cold lysis buffer (1%
NP-40, 0.5% Deoxycholate, 1% SDS, 150 mmol/L NaCl, 50 mmol/L Tris–HCl, pH = 8)
supplemented with a mixture of protease inhibitors (Cell Signaling Technology, USA). In
soluble protein in each lens homogenate was removed by centrifugation in a microcentrifuge
(14000 rpm, 30 min, 4° C). Protein levels in the remaining supernatant were measured
according to Bradford Assay (Bradford, 1976) and 50 micrograms of total protein from each
rat lens homogenate was separated in precast linear 4–15% tris-HCl gradient polyacrylamide
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gel (Ready Gels, BIO-Rad, Hercules, CA). The separated proteins were electrophoretically
transferred to nitrocellulose membrane, blocked with a 5% powdered milk solution and
washed with tris-buffered saline (TBS). The membranes were then separately incubated
overnight at 4° with antibodies against bFGF, TGF-β, Phospho-Akt, phospho-ERK1/2, and
phospho-SAPK/JNK in accordance with the manufacturer’s instructions. After final
washings with 0.05% TBS-Tween, membranes bound antibody complexes were visualized
by applying HRP conjugated anti-rabbit antibody to the membrane for 1 hr at room
temperature. The blots were again washed with TBS and processed for chemiluminescence
detection of the immunoreactive proteins after incubation for 5 min at room temperature.
Immunoreactive band densities were measured using Image-Pro Plus software (Bethesda,
MD).
Statistical Analysis
Analyses were conducted with the ANOVA software on ProStat ver. 5.01 (Pearl River, NY)
and Origin Pro 8.1 (OriginLab Corporation, Northampton, MA). All results with a p ≤
0.05% were considered to be significant.
Results
Tail vein injection of streptozotocin into young Sprague Dawley rats resulted in the
induction of diabetes with all rats demonstrating blood glucose levels >300 mg/dL. Ten days
after the induction of diabetes, select groups of the diabetic rats received rat chow containing
either 0.015% tolrestat or 0.0125% AL1576. Consumption studies indicated that the diabetic
rats ingested an average estimated dose (mean ± S.D.) of 23.9 ± 4.6 mg/kg/day for tolrestat
and 16.4 ± 0.9 mg/kg/day of AL1576. Glycosylated hemoglobin measurements conducted at
the 10 week conclusion of the study demonstrated that all diabetic groups were equally
hyperglycemic with mean HbA1c values (± SD) of 10.95 ± 0.36 for untreated diabetic rats,
10.76 ± 0.45 for diabetic rats treated with tolrestat; and 10.48 ± 0.86 for diabetic rats treated
with AL1576.
Lens opacities rapidly developed in all untreated diabetic rats with strong cortical to mature
cataracts present by the end of the 10 week study. In contrast, only minor lens changes,
primarily suture accentuation, developed in the tolrestat treated rats while no lens changes
were observed in AL1576 treated rats. As anticipated, cataract formation correlated with
increased sorbitol levels and reduced glutathione (GSH) levels which were normalized by
AL1576 treatment but only partially increased by tolrestat where cataract formation was not
fully arrested (Table 1). These observations correspond to previously published reports
(Kador et al., 2000; Lou et al., 1988; Simard-Duquesne et al., 1985) and are presented only
to demonstrate that the lenses subsequently analyzed conformed to established biochemical
parameters associated with sugar cataract formation.
Lens changes associated with diabetic hyperglycemia can be reproduced by culturing intact
lenses in medium containing 30 mM sugars (Obazawa et al., 1974). To assess the effects of
sorbitol formation in lenses, rat lenses were cultured for 24 and 48 hours in TC-199 –
bicarbonate culture media containing 30 mM glucose with/without 10 µM of the ARIs
AL1576, tolrestat, 10 µM of the SDI CP-166,572, or 15 mM mannitol. Control lenses were
cultured in TC-199 – bicarbonate media containing 30 mM fructose. While no changes in
lens clarity were apparent in the glucose cultured lenses, distinct time dependent
biochemical changes developed with greater differences observed after 48 hours. Therefore,
only the 48 hour results which are representative of the early stage of sugar cataract
formation are presented. Compared to control lenses cultured in 30 mM fructose media,
lenses cultured in 30 mM glucose media demonstrated increased sorbitol levels in the order:
AL1576-treated < tolrestat-treated < glucose alone < glucose and mannitol < SDI-treated
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(Fig 1a). The accumulation of sorbitol resulted in a slight increase in lens wet weights due to
lens hydration (Kinoshita, 1974; Mizuno et al., 1990). However, lenses cultured in the
osmotically compensated medium containing 30 mM glucose and 15 mM mannitol did not
increase in wet weight, presumably because the increased osmolarity in the culture medium
by mannitol which does not enter the lens counterbalanced the sorbitol-linked osmotic
gradient that formed within the lens so that no increase in lens hydration could occur.
Increased sorbitol levels and osmotic stress have been linked to reduced GSH levels in the
lens and reduced GSH levels have been reported to be associated with oxidative stress (Lee
and Chung, 1999; Mulhern et al., 2006; Obrosova et al., 1999). Compared to the fructose-
cultured controls, a significant decrease in GSH levels was observed with sorbitol
accumulation in lenses cultured in only 30 mM glucose media (Fig 1b). This significant
GSH decrease was not observed when lenses were cultured in 30mM glucose medium
containing ARI where sorbitol formation was inhibited. In addition, no significant decrease
in GSH levels was observed when lenses were cultured in the osmotically compensated
medium containing 30mM glucose and 15 mM mannitol despite an increase of sorbitol.
GSH levels were also not significantly reduced in lenses cultured for 48 hours in glucose
medium containing SDI despite the high levels of sorbitol produced by the inhibition of
sorbitol metabolism to fructose.
Cataract formation associated with diabetes has also been linked to changes in growth
factors and signaling expressions (Srivastava et al., 2005; Zatechka et al., 2003). In the
present study, lenses from diabetic rats demonstrated increased expression of the growth
factors bFGF and TGF-β and this increase did not occur in the lenses from diabetic rats
treated with either AL1576 or tolrestat (Fig 2a, 3a). A similar increase in the expression
level of these growth factors was observed in lenses cultured in medium containing either 30
mM glucose alone or 30 mM glucose and SDI (Fig 2b, 3b,). No increase in the expression of
these growth factors was observed when lenses were cultured in 30 mM glucose media
containing ARIs or with the glucose media containing 15 mM mannitol. To confirm that the
induction of bFGF and TGF-β were not specifically linked to sorbitol itself, the lenses were
also cultured in galactose where similar results were obtained. These studies demonstrate
that bFGF and TGF-β are synthesized directly within the lens. Furthermore, lenses cultured
in the osmotically compensated medium clearly indicate that this induction is not directly
due to the increased AR activity or lenticular accumulation of polyol, but to the lens’ ability
to react to osmotic stress.
The presence of bFGF and TGF-β are linked to cellular signaling changes. This was
confirmed in the present studies where the increased expression of these growth factors was
accompanied by increased signaling of P-Akt, P-ERK1/2, and P-SAPK/JNK both the in vivo
diabetic lenses and the in vitro lenses cultured in 30 mM glucose or 30 mM galactose media
(Fig 6, Table 2). No induction of signaling was observed in lenses either from diabetic rats
treated with ARIs or cultured with ARIs. Again, no increase in signaling was observed in
lenses cultured in osmotically compensated medium.
Discussion
Diabetes mellitus associated hyperglycemia can result in large and sudden increases in
aqueous glucose concentrations that, as a result of increased aqueous osmolarity, can
dehydrate the lens (Cameron et al., 2001; DiMattio et al., 1981). To diminish potential lens
dehydration, sorbitol, an organic osmolyte that is part of the physiological osmoregulatory
mechanism, is intracellularly produced to increase lens osmolarity (Chylack et al., 1986).
Once formed, the polar nature of sorbitol prevents its rapid removal from within the lens
cells. As a result, an osmotic gradient favoring hydration of the sorbitol containing cells is
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formed when hyperglycemia is reduced. This hydration is accentuated by rapid decreases in
blood and aqueous glucose levels which can magnify the osmotic differences between the
lens cells and aqueous, leading to an additional accumulation of water and hyperopia.
Kinoshita was the first to demonstrate the hyperosmotic effects of intracellular sorbitol or
galactitol accumulation and to postulate that the resulting cellular swelling can lead to
increased membrane permeability and a series of complex biochemical changes associated
with sugar cataract formation (Kador and Kinoshita, 1984; Kinoshita, 1974; Kinoshita et al.,
1979). The central role of AR in sugar cataract formation has been confirmed by the ability
of ARIs to prevent sugar cataract formation in diabetic or galactosemic animals (Kador and
Kinoshita, 1984; Kador et al., 2010b; Kinoshita, 1974; Mizuno et al., 1990).
It has also been suggested that hyperglycemia leads to oxidative stress, the depletion of the
critical lens antioxidant GSH, and damage to lens transport proteins involved in regulating
lens fibers (Crabbe and Goode, 1998; Kador, 2008; Kyselova et al., 2004; Lou, 2003; Lou et
al., 1988). The relationship between osmotic and oxidative stress and cataract formation
remains undefined with discussions of the relative importance of osmotic versus oxidative
stress based on observations that both ARIs and antioxidants can interfere with the onset and
progression of sugar cataract formation (Chung et al., 2003). It has also been demonstrated
that leaky membranes in the lenses under hyperglycemic conditions prevent ample supplies
of precursors for GSH synthesis, resulting in severe loss of GSH (Lou et al., 1988). In
addition, sorbitol-induced osmotic stress can induce endoplasmic reticulum (ER) stress that
is linked to the initiation of an unfolded protein response (UPR) that generates reactive
oxygen species (ROS) (Mulhern et al., 2006; Mulhern et al., 2007). This supports the
premise that sorbitol accumulation and osmotic stress precede oxidative stress in sugar
cataract formation (Obrosova et al., 1999).
Experimentally, the progression of biochemical changes in sugar cataract formation can be
investigated in vitro by culturing lenses in TC-199-bicarbonate media containing reducing
sugars such as glucose, galactose or xylose (Obazawa et al., 1974). This method has been
used in the present study with ARIs, an SDI, and osmotically compensated media (15 mM
mannitol) to gain insight into the importance of osmotic stress on cataract formation. Using
30 mM glucose to simulate the hyperglycemic environment associated with diabetes
mellitus resulted in increased sorbitol formation and lowered GSH levels after 48 hours of
culture (Fig 1). While this time frame did not result in significant opacity formation,
increases occurred both in the expression of the growth factors bFGF and TGF-β and
activation of signaling components of P-Akt, PERK1/2, and P-SAPK/JNK. A similar
increase in growth factor and activation of signaling components were also observed when
lenses were cultured in 30 mM glucose plus SDI despite the fact that sorbitol levels in the
SDI treated lenses were higher than in those lenses cultured in glucose alone (Fig 1A).
Williamson has suggested (Williamson et al., 1993) that excess sorbitol dehydrogenase
activity, which utilizes NAD+, can lead to an increase of NADH/NAD+ that can result in a
state of oxidative stress "pseudohypoxia", that is similar to that observed in hypoxic tissues
in diabetes mellitus. Therefore, inhibition of sorbitol dehydrogenase with an SDI should be
beneficial in reducing oxidative stress linked to increased production of NADH. Since a
number of in vivo studies have shown that administration of an SDI actually enhances
cataract formation in diabetic rats (Geisen et al., 1994; Kador et al., 1998; Obrosova et al.,
1999), we were surprised to find that the GSH levels were also not reduced in lenses
cultured with SDI at this time point. This suggests that in this initial 48 hour culture period
the SDI may contribute in reducing oxidative stress in the lens through the reduction of the
“pseudohypoxia”. Nevertheless, despite the lack of GSH loss, an increased expression in
both the growth factors bFGF and TGF-β and signaling though P-Akt, P-ERK1/2, and P-
SAPK/JNK, were observed in the SDI-treated lenses similar to those lenses cultured in 30
mM glucose alone.
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The presence of the growth factors bFGF and TGF-β and their influence on cellular
signaling are also linked to cataract formation (deLongh et al., 2005; Lovicu et al., 2011).
Zatecha et al observed in diabetic rats that bFGF accumulates in the vitreous and alters
downstream MAPK signaling and the upregulation of phosphorylated ERK and the common
stress-associated mitogen-activated protein kinases p38 and SAPK/JNK. These events were
normalized in similar rats treated with the ARI AL1576 (Zatechka et al., 2003).
Subsequently, Kubo et al have reported that mRNA and protein levels of TFG-β increase in
the lenses of diabetic rats (Kubo et al., 2005).
The present in vivo and in vitro studies both demonstrate that an intracellular induction of
bFGF and TGF-β and subsequent signaling changes occur immediately after the lens
responds to osmotic stress induced by polyol accumulation. Because growth factors were not
added to the culture media, the present study also demonstrates that the lenses in response to
osmotic stress directly synthesize bFGF and TGF-β. This is in contrast to many studies
where lenses are exposed to an external source of growth factors added to the medium of
cultured lenses. It has been proposed that cataract formation many actually be influenced by
the aqueous humor because it is a rich “outside” source of growth factors, many of which
have been shown to be lens cell mitogens that primarily signal through the MAPK/ERK and
PI3-K/Akt pathway (Iyengar et al., 2009). Culturing rat lenses in TGF-β actually results in
cataract formation, which is exacerbated by the presence of bFGF (Cerra et al., 2003; Lovicu
et al., 2004). In these cultured lenses, GSH strongly suppressed TGF-β-induced
opacification and subcapsular plaque formation (Chamberlain et al., 2009). However, in our
studies GSH levels did not appear to influence the induction of TGF-β. Several clinical
studies report that aqueous TGF-β2 levels are higher in diabetics with or without
neovascular glaucoma (Min et al., 2006; Ochiai and Ochiai, 2002). Similarly, bFGF levels
are higher in the aqueous of diabetics with macular edema (Jonas and Neumaier, 2007).
None of these studies, however, mention cataracts.
In summary, the present studies suggest that AR catalyzes the intracellular accumulation of
sorbitol in the lens epithelium and superficial cortical fibers in response to hyperglycemia.
While sorbitol accumulation can cause a hyperosmotic imbalance within the sorbitol
accumulating cells, it does not directly reduce GSH levels, suggesting glucose-linked
oxidation may not occur. When the sorbitol accumulating lens cells finally respond to the
osmotic stress, the synthesis of TGF-β and bFGF are initiated. At the same time, induction
of GRP78 in the lens indicates that ER stress-associated ROS generation occurred. The
observed induction of growth factors and signaling suggest that these initially may be
protective in nature; however, the prolonged presence of TGF-β and signaling perturbation
may contribute to the final cataract formation.
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Figure 1.
Sorbitol (A) and reduced glutathione levels (B) in lenses cultured for 48 hours in TC-199 -
bicarbonate media supplemented with either 30 mM fructose (control) or 30 mM glucose
(hGlu) with/without the aldose reductase inhibitors AL1576 or tolrestat, or the sorbitol
dehydrogenase inhibitor CP-166,572 (SDI), or 30 mM glucose and 15 mM mannitol (hGlu
Mannitol). Mean ± SEM; n= 4. * significantly different (p ≤ 0.05) from control.
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Figure 2.
Comparison of expression levels of the growth factor bFGF normalized to GAPDH in (A)
lenses from 10 week diabetic rats treated with/without AL1576 or tolrestat and age matched
nondiabtic rats and (B) in lenses cultured for 48 hours in TC-199 - bicarbonate media
supplemented with either 30 mM fructose (control) or 30 mM glucose (hGlu) with/without
the aldose reductase inhibitors AL1576 or tolrestat, or the sorbitol dehydrogenase inhibitor
CP-166,572 (SDI), or 30 mM glucose and 15 mM mannitol (hGlu Mannitol). Mean ± SEM;
n= 4–7. * significantly different (p ≤ 0.05) from control.
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Figure 3.
Comparison of expression levels of the growth factor TGF-β normalized to GAPDH in (A)
lenses from 10 week diabetic rats treated with/without AL1576 or tolrestat and age matched
nondiabtic rats and (B) in lenses cultured for 48 hours in TC-199 - bicarbonate media
supplemented with either 30 mM fructose (control) or 30 mM glucose (hGlu) with/without
the aldose reductase inhibitors AL1576 or tolrestat, or the sorbitol dehydrogenase inhibitor
CP-166,572 (SDI), or 30 mM glucose and 15 mM mannitol (hGlu Mannitol). Mean ± SEM;
n= 4–7. * significantly different (p ≤ 0.05) from control.
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Figure 4.
Comparison of expression levels of phosphorylated-Akt normalized to GAPDH in (A)
lenses from 10 week diabetic rats treated with/without AL1576 or tolrestat and age matched
nondiabtic rats and (B) in lenses cultured for 48 hours in TC-199 - bicarbonate media
supplemented with either 30 mM fructose (control) or 30 mM glucose (hGlu) with/without
the aldose reductase inhibitors AL1576 or tolrestat, or the sorbitol dehydrogenase inhibitor
CP-166,572 (SDI), or 30 mM glucose and 15 mM mannitol (hGlu Mannitol). Mean ± SEM;
n= 4-7. * significantly different (p ≤ 0.05) from control.
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Figure 5.
Comparison of expression levels of phosphorylated ERK1/2 normalized to GAPDH in (A)
lenses from 10 week diabetic rats treated with/without AL1576 or tolrestat and age matched
nondiabtic rats and (B) in lenses cultured for 48 hours in TC-199 - bicarbonate media
supplemented with either 30 mM fructose (control) or 30 mM glucose (hGlu) with/without
the aldose reductase inhibitors AL1576 or tolrestat, or the sorbitol dehydrogenase inhibitor
CP-166,572 (SDI), or 30 mM glucose and 15 mM mannitol (hGlu Mannitol). Mean ± SEM;
n= 4–7. * significantly different (p ≤ 0.05) from control.
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Figure 6.
Comparison of expression levels of phosphorylated SAPK/JNK normalized to GAPDH in
(A) lenses from 10 week diabetic rats treated with/without AL1576 or tolrestat and age
matched nondiabtic rats and (B) in lenses cultured for 48 hours in TC-199 - bicarbonate
media supplemented with either 30 mM fructose (control) or 30 mM glucose (hGlu) with/
without the aldose reductase inhibitors AL1576 or tolrestat, or the sorbitol dehydrogenase
inhibitor CP-166,572 (SDI), or 30 mM glucose and 15 mM mannitol (hGlu Mannitol). Mean
± SEM; n= 4–7. * significantly different (p ≤ 0.05) from control.
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Table 1
Lens sorbitol and reduced glutathione levels from streptozotocin-induced diabetic rats fed diet with/without
the aldose reductase inhibitors AL1576 or tolrestat for 10 weeks or their age-matched nondiabetic controls.
Mean ± SEM; n= 4.
Group Sorbitol
(µg/lens)
GSH
(nmol/lens)
Control 5.1 ± 5.1 54.1 ± 1.0
Diabetic 151.9 ± 21.3 * 19.5 ± 1.6*
Diabetic + AL1576 12.7 ± 2.6 51.0 ± 6.9
Diabetic + Tolrestat 19.6 ± 7.7 39.9 ± 3.0*
*
significantly different (p ≤ 0.05) from control.
Exp Eye Res. Author manuscript; available in PMC 2013 August 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Zhang et al. Page 19
Ta
bl
e 
2
G
al
ac
to
se
 S
tu
dy
 R
es
ul
ts
 
R
at
 le
ns
es
 c
ul
tu
re
d 
fo
r 4
8 
ho
ur
s i
n 
TC
-1
99
 - 
bi
ca
rb
on
at
e m
ed
ia
 su
pp
le
m
en
te
d 
w
ith
 ei
th
er
 3
0 
m
M
 fr
uc
to
se
 (c
on
tro
l) 
or 
30
 m
M
ga
la
ct
os
e 
(hG
al)
 w
ith
/w
ith
ou
t th
e a
ldo
se 
red
uc
tas
e i
nh
ibi
tor
s A
L1
57
6 o
r t
olr
est
at,
 or
 th
e s
orb
ito
l d
eh
yd
rog
en
ase
 in
hib
ito
r C
P-
16
6,5
72
 (S
DI
), o
r 3
0 m
M
ga
la
ct
os
e 
an
d 
15
 m
M
 m
an
ni
to
l (
hG
al 
M
an
nit
ol)
 sh
ow
ing
 ro
w 
1:
 le
ns
 g
al
ac
tit
ol
 le
ve
ls 
(µm
ol/
mg
 pr
ote
in)
, ro
w 
2–
3:
 
in
du
ct
io
n 
of
 b
FG
F 
an
d 
TG
F-
β a
n
d 
ro
w
4–
6:
 
th
e 
ex
pr
es
sio
n 
le
ve
ls 
of
 p
ho
sp
ho
ry
la
te
d 
SA
PK
/JN
K
, p
ho
sp
ho
ry
la
te
d 
ER
K
1/
2,
 a
nd
 p
ho
sp
ho
ry
la
te
d 
A
kt
. A
ll 
gr
ow
th
 fa
ct
or
 a
nd
 si
gn
al
in
g 
ex
pr
es
sio
ns
w
er
e 
n
o
rm
al
iz
ed
 to
 G
A
PD
H
. M
ea
n 
± 
SE
M
; n
= 
4.
C
on
tr
ol
hG
al
hG
al
A
L1
57
6
hG
al
To
lr
es
ta
t
hG
al
SD
I
hG
al
M
an
ni
to
l
G
al
ac
tit
ol
0#
90
.3
 ±
 3
.2
1.
2 
± 
.3
#
27
.3
 ±
 1
.4
#
89
.4
 ±
 2
.9
87
.7
 ±
 3
.7
bF
G
F
0.
61
 ±
 0
.0
6
0.
84
 ±
0.
01
*
0.
70
 ±
 0
.0
2
0.
71
 ±
 0
.0
6
0.
81
 ±
 0
.0
3*
0.
68
 ±
 0
.0
4
TG
F-
β
0.
68
 ±
 0
.1
6
0.
90
 ±
 0
.1
2*
0.
75
 ±
 0
.0
2
0.
69
 ±
 0
.0
2
0.
93
 ±
 0
.0
7
0.
79
 ±
 0
.0
4
p-
SA
PK
/J
NK
0.
62
 ±
 0
.0
8
0.
84
 ±
 0
.0
2*
0.
66
 ±
 0
.0
6
0.
57
 ±
 0
.0
9
0.
84
 ±
 0
.0
2*
0.
72
 ±
 0
.0
4
p-
ER
K
 1
/2
0.
67
 ±
0.
06
0.
96
 ±
 0
.0
2*
0.
76
 ±
 0
.0
5
0.
69
 ±
 0
.0
4
0.
94
 ±
 0
.0
2*
0.
72
 ±
 0
.1
0
p-
A
kt
0.
54
 ±
 0
.0
5
0.
89
 ±
 0
.1
3*
0.
67
 ±
 0
.0
5
0.
63
 ±
 0
.0
2
0.
81
 ±
 0
.0
4*
0.
65
 ±
 0
.1
0
# s
ig
ni
fic
an
tly
 d
iff
er
en
t (
p ≤
 0.
05
) f
rom
 th
e u
ntr
ea
ted
 hG
al 
gro
up
 or
*
sig
ni
fic
an
tly
 d
iff
er
en
t (
p ≤
 0.
05
) f
rom
 co
ntr
ol 
gro
up
.
Exp Eye Res. Author manuscript; available in PMC 2013 August 01.
